The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Neuralstem (CUR) announced a $19.65M registered direct offering on Friday morning. Recall that Jason Napodano of Zacks Small-Cap Research has covered Neuralstem at length for … Continue Reading
Read nowResearch - Since our initial report on Pharmacyclics (PCYC) on February 11, shares of the oncology company have returned almost 52%. Pharmacyclics’ relative underperformance to the NASDAQ … Continue Reading
Read nowInsights - It’s New Year’s Eve. This year flew past – and so did biotech. The NASDAQ Biotechnology Index (NBI) will end the year up 60%, while … Continue Reading
Read nowInsights - Threshold Pharmaceuticals (THLD) announced that the target enrollment of 620 patients with advanced soft tissue sarcoma has been achieved in the company’s pivotal phase 3 … Continue Reading
Read nowInsights - It’s been a banner year in biotech, and one of PropThink’s top picks in 2013, Keryx Biopharmaceuticals (KERX), has outperformed significantly as one of the … Continue Reading
Read nowResearch - Since we last profiled Cubist Pharmaceuticals (CBST) in August, shares of the antibiotics company have posted a somewhat muted performance, rising less than 8% versus … Continue Reading
Read nowRecap - Happy holidays from the PropThink editorial team! We hope you’re enjoying time with friends and family as we wrap up another busy holiday season and … Continue Reading
Read now
